These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system. Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298 [TBL] [Abstract][Full Text] [Related]
27. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma. Hashida N; Nakai K; Saitoh N; Nishida K Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401 [TBL] [Abstract][Full Text] [Related]
28. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS. Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309 [TBL] [Abstract][Full Text] [Related]
29. An unusual case report of primary vitreoretinal lymphoma. Tan SZ; Steeples LR; Chhabra R; Jones NP BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824 [TBL] [Abstract][Full Text] [Related]
30. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. Levasseur SD; Wittenberg LA; White VA JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208 [TBL] [Abstract][Full Text] [Related]
31. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554 [TBL] [Abstract][Full Text] [Related]
32. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma. Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288 [TBL] [Abstract][Full Text] [Related]
37. Multimodal Imaging of Vitreoretinal Lymphoma. Mapelli C; Invernizzi A; Barteselli G; Pellegrini M; Tabacchi E; Staurenghi G; Viola F Ophthalmologica; 2016; 236(3):166-174. PubMed ID: 27627063 [TBL] [Abstract][Full Text] [Related]
38. Eye involvement in primary central nervous system lymphoma. Farrall AL; Smith JR Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762 [TBL] [Abstract][Full Text] [Related]